Breakdown | ||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
14.16B | 17.92B | 17.15B | 12.78B | 11.52B | Gross Profit |
3.22B | 3.86B | 3.11B | 2.15B | 1.87B | EBIT |
1.31B | 1.31B | 805.50M | 201.09M | 240.63M | EBITDA |
1.44B | 1.64B | 1.08B | 552.06M | 1.02B | Net Income Common Stockholders |
905.57M | 956.66M | 563.57M | 229.71M | 484.94M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.00B | 6.86B | 5.71B | 4.02B | 3.86B | Total Assets |
20.30B | 21.41B | 15.95B | 14.74B | 11.81B | Total Debt |
8.46B | 9.31B | 5.66B | 6.49B | 5.13B | Net Debt |
1.46B | 2.45B | -51.10M | 2.47B | 1.28B | Total Liabilities |
16.20B | 17.24B | 13.57B | 12.88B | 10.13B | Stockholders Equity |
4.10B | 4.16B | 2.38B | 1.86B | 1.68B |
Cash Flow | Free Cash Flow | |||
0.00 | -3.29B | 2.19B | -1.86B | -1.06B | Operating Cash Flow |
0.00 | 1.31B | 3.43B | -745.18M | -338.97M | Investing Cash Flow |
0.00 | -4.65B | -1.43B | -707.64M | 928.45M | Financing Cash Flow |
0.00 | 4.46B | -884.25M | 1.31B | -369.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥8.53B | 8.84 | 2.31% | ― | ― | ||
78 Outperform | ¥10.55B | 14.34 | 1.39% | 20.50% | 62.52% | ||
74 Outperform | ¥3.02B | 8.08 | 2.51% | 2.33% | -0.96% | ||
69 Neutral | ¥10.19B | 18.41 | 1.24% | 21.97% | -20.94% | ||
61 Neutral | ¥9.30B | 20.94 | ― | 10.60% | 15.95% | ||
61 Neutral | $939.25M | 5.80 | 2.43% | 4.01% | 10.27% | -74.96% | |
58 Neutral | ¥5.36B | 12.24 | 4.31% | 10.13% | ― |